Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VERACYTE, INC. Director's Dealing 2020

Aug 5, 2020

31551_dirs_2020-08-04_04451cb4-d22b-449b-af5f-9bfa70352f2c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2020-07-31

Reporting Person: Hanna John Walter JR (Chief Commercial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-07-31 Common Stock M 14095 $8.86 Acquired 88729 Direct
2020-07-31 Common Stock S 14095 $36.1224 Disposed 74634 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-07-31 Stock Option (right to buy) $8.86 M 14095 Disposed 2025-03-01 Common Stock (14095) Direct

Footnotes

F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019.

F2: Includes 110 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.

F3: Represents weighted average sales price. Sale prices for the transactions range from $36.00 to $36.35. Detailed information regarding the number of shares sold at each separate price will be provided to the
SEC, the issuer or a shareholder upon request.

F4: The option is fully vested.